(Q73269108)

English

A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer

scientific article published on 01 October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

H Oettle

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Arning

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

U Pelzer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Stroszczynski

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Langrehr

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Reitzig

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Kindler

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Herrenberger

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Musch

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E W Korsten

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Huhn

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Riess

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1267-1272

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced and metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in the treatment of cancer of the pancreas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical recommendations for the management of adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of gemcitabine in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364018881

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008364018881

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106115%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73269108&oldid=1967260635"